NmFGF1-Regulated Glucolipid Metabolism and Angiogenesis Improves Functional Recovery in a Mouse Model of Diabetic Stroke and Acts via the AMPK Signaling Pathway

Abstract

Diabetes increases the risk of stroke, exacerbates neurological deficits, and increases mortality. Non-mitogenic fibroblast growth factor 1 (nmFGF1) is a powerful neuroprotective factor that is also regarded as a metabolic regulator. The present study aimed to investigate the effect of nmFGF1 on the improvement of functional recovery in a mouse model of type 2 diabetic (T2D) stroke. We established a mouse model of T2D stroke by photothrombosis in mice that were fed a high-fat diet and injected with streptozotocin (STZ). We found that nmFGF1 reduced the size of the infarct and attenuated neurobehavioral deficits in our mouse model of T2D stroke. Angiogenesis plays an important role in neuronal survival and functional recovery post-stroke. NmFGF1 promoted angiogenesis in the mouse model of T2D stroke. Furthermore, nmFGF1 reversed the reduction of tube formation and migration in human brain microvascular endothelial cells (HBMECs) cultured in high glucose conditions and treated with oxygen glucose deprivation/re-oxygenation (OGD). Amp-activated protein kinase (AMPK) plays a critical role in the regulation of angiogenesis. Interestingly, we found that nmFGF1 increased the protein expression of phosphorylated AMPK (p-AMPK) both in vivo and in vitro. We found that nmFGF1 promoted tube formation and migration and that this effect was further enhanced by an AMPK agonist (A-769662). In contrast, these processes were inhibited by the application of an AMPK inhibitor (compound C) or siRNA targeting AMPK. Furthermore, nmFGF1 ameliorated neuronal loss in diabetic stroke mice via AMPK-mediated angiogenesis. In addition, nmFGF1 ameliorated glucose and lipid metabolic disorders in our mouse model of T2D stroke without causing significant changes in body weight. These results revealed that nmFGF1-regulated glucolipid metabolism and angiogenesis play a key role in the improvement of functional recovery in a mouse model of T2D stroke and that these effects are mediated by the AMPK signaling pathway.

Diallyl Trisulfide Enhances the Survival of Multiterritory Perforator Skin Flaps

“…Previous studies have shown that DATS can protect cardiomyocytes from I/R injury through the AMPK pathway ( Yu et al, 2017b ). At the same time, the increased expression of AMPK and HIF-1α can promote angiogenesis and reduce oxidative stress ( Choi et al, 2017 ; Zhao et al, 2021 ). Our results showed that p -AMPK and HIF-1α were increased in the DATS group and DATS+3MA group, and the difference between these two groups was not obvious.…”

Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases

“…Diabetic retinopathy (DR) is a retinal microvascular disease caused by chronic hyperglycemia leading to angiogenesis in retina (Ai et al, 2019). In recent years, improvement of disordered glucolipid metabolism is considered one of the most effective strategies for the treatment of DM and its complications (Zhao et al, 2021b). Berberine has been shown to block DR development by modulating the glucolipid metabolism and inhibiting the HIF-1α/VEGF/NF-κB pathway (Yin et al, 2021).…”

The Role of Polyphenol in Modulating Associated Genes in Diabetes-Induced Vascular Disorders

“…Inhibition of AMPK activation also causes vasoconstriction in arteries through inhibition of endothelial KCa channels activity. The diminution of endothelial AMPK aggravates oxidative stress, inflammation, and apoptosis, which limits endothelial metabolism by downregulating β-oxidation of free FFAs and glycolysis [ 76 , 77 ]. In VSMCs, AMPK directly contracts VSMCs by increasing Ca 2+ mechanisms, decreasing sarcoplasmic/endoplasmic reticulum calcium ATPase activity, deactivation of KATP and BKCa channels resulting in hypopolarization, and activation of Ca 2+ entry through VOC channels under hyperglycemia [ 78 ].…”